MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome. 2021

Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
Division of Nephrology, Nanfang Hospital, Southern Medical University, State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou 510515, China.

NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome activation has emerged as a central mediator of kidney inflammation in diabetic kidney disease (DKD). However, the mechanism underlying this activation in DKD remains poorly defined. In this study, we found that kidney-enriched microRNA-10a and -10b (miR-10a/b), predominantly expressed in podocytes and tubular epithelial cells, were downregulated in kidney from diabetic mice and patients with DKD. High glucose decreased miR-10a/b expression in vitro in an osmolarity-independent manner. miR-10a/b functioned as negative regulators of the NLRP3 inflammasome through targeting the 3'untranslated region of NLRP3 mRNA, inhibiting assembly of the NLRP3 inflammasome and decreasing caspase-1-dependent release of pro-inflammatory cytokines. Delivery of miR-10a/b into kidney prevented NLRP3 inflammasome activation and renal inflammation, and it reduced albuminuria in streptozotocin (STZ)-treated mice, whereas knocking down miR-10a/b increased NLRP3 inflammasome activation. Restoration of miR-10a/b expression in established DKD ameliorated kidney inflammation and mitigated albuminuria in both db/db and STZ-treated mice. These results suggest a novel intervention strategy for inhibiting kidney inflammation in DKD by targeting the NLRP3 inflammasome.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071199 NLR Family, Pyrin Domain-Containing 3 Protein An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME. Cold Autoinflammatory Syndrome 1 Protein,NACHT, LRR and PYD Domains-Containing Protein 3,NLRP3 Protein,NACHT, LRR and PYD Domains Containing Protein 3,NLR Family, Pyrin Domain Containing 3 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse
D050199 Podocytes Highly differentiated epithelial cells of the visceral layer of BOWMAN CAPSULE of the KIDNEY. They are composed of a cell body with major CELL SURFACE EXTENSIONS and secondary fingerlike extensions called pedicels. They enwrap the KIDNEY GLOMERULUS capillaries with their cell surface extensions forming a filtration structure. The pedicels of neighboring podocytes interdigitate with each other leaving between them filtration slits that are bridged by an extracellular structure impermeable to large macromolecules called the slit diaphragm, and provide the last barrier to protein loss in the KIDNEY. Visceral Epithelial Cells, Glomerular,Epithelial Cells, Glomerular Visceral,Glomerular Visceral Epithelial Cells,Podocyte

Related Publications

Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
September 2021, International journal of molecular medicine,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
January 2020, Biochemical and biophysical research communications,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
November 2015, Biochemical and biophysical research communications,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
November 2017, Journal of immunology (Baltimore, Md. : 1950),
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
May 2015, American journal of physiology. Lung cellular and molecular physiology,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
March 2024, The Journal of biological chemistry,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
April 2020, International immunopharmacology,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
December 2017, Nature communications,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
November 2014, FEBS letters,
Hanying Ding, and Jinxiang Li, and Yang Li, and Minliang Yang, and Sheng Nie, and Miaomiao Zhou, and Zhanmei Zhou, and Xiaobing Yang, and Youhua Liu, and Fan Fan Hou
January 2022, Discovery medicine,
Copied contents to your clipboard!